Expert Outlook: Tempus AI Through The Eyes Of 6 Analysts

Tempus AI, Inc. Class A -0.19% Pre

Tempus AI, Inc. Class A

TEM

47.30

47.21

-0.19%

-0.19% Pre

Tempus AI (NASDAQ:TEM) underwent analysis by 6 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.

The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.

Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish
Total Ratings 2 3 1 0 0
Last 30D 1 0 0 0 0
1M Ago 0 2 0 0 0
2M Ago 0 0 0 0 0
3M Ago 1 1 1 0 0

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $82.33, a high estimate of $100.00, and a low estimate of $59.00. Highlighting a 9.78% decrease, the current average has fallen from the previous average price target of $91.25.

price target chart

Diving into Analyst Ratings: An In-Depth Exploration

The standing of Tempus AI among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target
Mark Massaro BTIG Lowers Buy $90.00 $105.00
Bradley Bowers Mizuho Announces Outperform $100.00 -
Catherine Schulte Baird Announces Outperform $59.00 -
Kyle Mikson Canaccord Genuity Lowers Buy $80.00 $95.00
Casey Woodring JP Morgan Lowers Neutral $80.00 $85.00
Tejas Savant Morgan Stanley Raises Overweight $85.00 $80.00

Key Insights:

  • Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Tempus AI. This offers insight into analysts' perspectives on the current state of the company.
  • Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Tempus AI compared to the broader market.
  • Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.

Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Tempus AI's market standing. Stay informed and make data-driven decisions with our Ratings Table.

Stay up to date on Tempus AI analyst ratings.

Delving into Tempus AI's Background

Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.

Tempus AI: Delving into Financials

Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.

Revenue Growth: Tempus AI's remarkable performance in 3M is evident. As of 30 September, 2025, the company achieved an impressive revenue growth rate of 84.72%. This signifies a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Health Care sector.

Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of -23.93%, the company may need to address challenges in effective cost control.

Return on Equity (ROE): Tempus AI's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of -19.57%, the company may encounter challenges in delivering satisfactory returns for shareholders.

Return on Assets (ROA): Tempus AI's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of -4.09%, the company may encounter challenges in delivering satisfactory returns from its assets.

Debt Management: Tempus AI's debt-to-equity ratio is notably higher than the industry average. With a ratio of 2.63, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.

Analyst Ratings: What Are They?

Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.

Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.

This article was generated by Benzinga's automated content engine and reviewed by an editor.